Sign in / Join Now
ETFs & Funds
AMITIZA treatment of opioid-induced constipation patients with chronic, non-cancer pain. FDA decision expected on 1/27/13. 250M
Add a reply...
Latest StockTalks »
people get SCMP breaking news and analysis by email alert.
Get email alerts on SCMP »
Sucampo Pharmaceuticals, Inc.
Get latest price
From other sites
Commit To Purchase Sucampo Pharmaceuticals At $10, Earn 16% Annualized Using Options
at TheStreet (Sep 27, 2016)
Sucampo Reports Second Quarter 2016 Financial Results
at TheStreet (Aug 3, 2016)
Paul Edick Joins Sucampo's Board Of Directors
at TheStreet (Jul 29, 2016)
Sucampo to Stop Developing Cobiprostone for Oral Mucositis
at Zacks.com (Jul 12, 2016)
The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
at Zacks.com (Apr 1, 2016)